EUVIMEDEUVIMED entdecken
Crossref

Funding Postauthorization Vaccine-Safety Science

Daniel A Salmon, Walter A Orenstein, Stanley A Plotkin, Robert T Chen

New England Journal of Medicine · 2024

DOI: 10.1056/nejmp2402379 ↗

Kurz gefasst

Fachartikel in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Daniel A Salmon und 3 weiteren Autor:innen. Beteiligte Einrichtung: From the Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore (D.A.S.); Emory University, Atlanta (W.O.); the Uni…. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Financing, Government, Product Surveillance, Postmarketing. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesFinancing, GovernmentProduct Surveillance, PostmarketingHumansUnited StatesUnited States Food and Drug AdministrationConsumer Product Safety

Substanzen

COVID-19 Vaccines

Autor:innen und Institutionen

  • From the Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health, Baltimore (D.A.S.); Emory University, Atlanta (W.O.); the University of Pennsylvania, Philadelphia (S.A.P.); and the Brighton Colla…

Zitieren

APA

Salmon, D. A., Orenstein, W. A., Plotkin, S. A., & Chen, R. T. (2024). Funding Postauthorization Vaccine-Safety Science. New England Journal of Medicine. https://doi.org/10.1056/nejmp2402379

Vancouver

Salmon DA, Orenstein WA, Plotkin SA, Chen RT. Funding Postauthorization Vaccine-Safety Science. New England Journal of Medicine. 2024. doi:10.1056/nejmp2402379

BibTeX
@article{Salmon2024,
  author = {Salmon, Daniel A and Orenstein, Walter A and Plotkin, Stanley A and Chen, Robert T},
  title = {Funding Postauthorization Vaccine-Safety Science},
  journal = {New England Journal of Medicine},
  year = {2024},
  doi = {10.1056/nejmp2402379}
}
Kostenlos starten →